A new year means new beginnings. I want to take this time to thank you for your patience with us over the last few months and share some very positive updates with you.
Product Supply Update
As many of you know, an earlier-than-expected approval of the MiniMed™ 670G system with SmartGuard™ technology, unprecedented demand for our sensors and a treacherous hurricane ripping through Puerto Rico (where our manufacturing facility is located) all contributed to inventory challenges for us in 2017. I know how much you depend on this technology. And I can only imagine how frustrating and scary shipment delays and backorders can be. I sincerely apologize to all of you who have experienced this.
Fortunately, today I have very good news to share:
- MiniMed 670G and MiniMed 630G systems are in stock and ready to meet demand.
- 99% of Priority Access orders have been fulfilled. We’ll be shipping the last few within the next month or so, barring a few exceptions for those with insurance issues (if this is you, we’ll work with you individually).
- Those who order a MiniMed 670G system today will receive both the pump and CGM starter kit as soon as we receive insurance approval.
- If you have a recent order of Guardian Sensor 3 sensors, you should see no more than a 2-3 day delay as we catch up on existing orders.
- Enlite™ sensors are available and you should not experience order delays
Want to learn more about the dedicated team in Puerto Rico working through the aftermath of Hurricane Maria to deliver your diabetes supplies? <<Click here>>>
I’d also like to thank our dedicated team in Puerto Rico who have been working incredibly hard to upgrade our facility and processes to help prevent future shortages – even while enduring many personal losses as a result of Hurricane Maria. Homes destroyed and without power or water, they showed up to work (without being asked) because of their commitment to you.
Expanded Financial Assistance Options
We continue to hear from you about how diabetes takes both an emotional and a financial toll on families with diabetes. Bringing forward innovation like the MiniMed 670G system to improve the lives of people with diabetes does require considerable investment. But we want to try to do what we can, when we can, to alleviate some of the financial burden of this disease. Here are a few new options we’ve introduced to help.
- Extended Payment Plans for as Low as $1/Day*
We now have payment plans that can distribute over 48 months to cover the co-pay for your pump, CGM starter kit and first 90 days of supplies. For many, this can be as low as $1/day. This program is available for anyone, no matter your financial situation.
- Temporary Coverage for Hard Times
Diabetes is hard and sometimes life makes it even harder. When it does, we’re here to help. We have special programs for special situations such as unemployment with the last 12 months, a gap in insurance coverage due to a pre-existing condition, multiple pumpers in one household and permanent disability.
The last thing I want is for finances to stand in the way of you having access to technology that could help you live a fuller, healthier life. If you’re interested in a new system or have found yourself having difficulty affording your supplies, we do want to work with you and may have even more financial assistance programs for you, depending on your situation. Please call us at 800.646.4633 option 4 so our team can see how we can help.
Customer Service Update
Unfortunately, the supply issues and product demand also put a lot of pressure on our customer care teams. I know that call hold times have been longer than typical, and call-backs are taking us more time than they should. This is not acceptable and my team and I hold ourselves to a higher standard.
To address this issue, we’ve staffed up our teams, streamlined processes and introduced programs like text message ordering and a new online store to make it easier for you to get what you need from us. Looking for ways to improve our customer care an ongoing effort, and it’s an area of particular focus for us right now. We are committed to providing you the best possible experience. You can hear from some of the employees working diligently to meet your expectations here.
You can hear from some of employees here.
Want to hear more inspiring stories of people like you living with diabetes? <<Click here>>
I feel very positive about the year ahead. We’re still working through some challenges, but we’ve taken significant steps to address them. We are, as always, incredibly inspired by you and the amazing lives you live with diabetes. I can’t wait for more of you to experience the MiniMed 670G system and look forward to your feedback. Your thoughts and experiences are so important to me and to the entire company. I’m listening and I’m Inspired by You
*No credit check required. Based on plan of 48 months.Individual plans vary.
IMPORTANT SAFETY INFORMATION
The Medtronic MiniMed 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, fourteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 670G system includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required.
A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site (palm) or from a control solution test. It is also not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the 670G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library
, insulin pump
, minimed 670g